Gene · 28996
Papers1,691
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,691
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of N6‑methyladenosine in the pathogenesis, diagnosis and treatment of pancreatic cancer (Review). | Int J Oncol | 2023 | 36367195 | PubTator, text mining | PubMed |
| HIPK2 in cancer biology and therapy: Recent findings and future perspectives. | Cell Signal | 2023 | 36241057 | PubTator, text mining | PubMed |
| Effects of writers, erasers and readers within miRNA-related m6A modification in cancers. | Cell Prolif | 2023 | 36162823 | PubTator, text mining | PubMed |
| Exosomes as Neurological Nanosized Machines. | ACS Nanosci Au | 2022 | 37102062 | PubTator, text mining | PubMed |
| Novel Variant Identified in the Enhancer Region of Host Transcription Factor, BRN3A, is a Significant Risk Factor for HPV-Induced Uterine Cervix Cancer. | Int J Mol Cell Med | 2022 | 37091039 | PubTator, text mining | PubMed |
| DNA methylation change of HIPK3 in Chinese rheumatoid arthritis and its effect on inflammation. | Front Immunol | 2022 | 36703984 | PubTator, text mining | PubMed |
| MicroRNAs in the Regulation of NADPH Oxidases in Vascular Diabetic and Ischemic Pathologies: A Case for Alternate Inhibitory Strategies? | Antioxidants (Basel) | 2022 | 36670932 | PubTator, text mining | PubMed |
| NRF2 in Cancer: Cross-Talk with Oncogenic Pathways and Involvement in Gammaherpesvirus-Driven Carcinogenesis. | Int J Mol Sci | 2022 | 36614036 | PubTator, text mining | PubMed |
| The Role of Bromodomain and Extraterminal (BET) Proteins in Controlling the Phagocytic Activity of Microglia In Vitro: Relevance to Alzheimer's Disease. | Int J Mol Sci | 2022 | 36613460 | PubTator, text mining | PubMed |
| Regulation of Kinase Signaling Pathways by α6β4-Integrins and Plectin in Prostate Cancer. | Cancers (Basel) | 2022 | 36612146 | PubTator, text mining | PubMed |
| Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU). | Front Immunol | 2022 | 36591282 | PubTator, text mining | PubMed |
| Network-based approach for targeting human kinases commonly associated with amyotrophic lateral sclerosis and cancer. | Front Mol Neurosci | 2022 | 36590916 | PubTator, text mining | PubMed |
| SPOP inhibits BRAF-dependent tumorigenesis through promoting non-degradative ubiquitination of BRAF. | Cell Biosci | 2022 | 36585710 | PubTator, text mining | PubMed |
| The sirtuin family in health and disease. | Signal Transduct Target Ther | 2022 | 36581622 | PubTator, text mining | PubMed |
| Non-coding RNAs: Role in diabetic foot and wound healing. | World J Diabetes | 2022 | 36578864 | PubTator, text mining | PubMed |
| MicroRNA-126-5p Facilitates Hypoxia-Induced Vascular Endothelial Cell Injury via HIPK2. | Ann Clin Lab Sci | 2022 | 36564067 | PubTator, text mining | PubMed |
| Crosstalk between Methylation and ncRNAs in Breast Cancer: Therapeutic and Diagnostic Implications. | Int J Mol Sci | 2022 | 36555400 | PubTator, text mining | PubMed |
| Circ_0083964 knockdown impedes rheumatoid arthritis progression via the miR-204-5p-dependent regulation of YY1. | J Orthop Surg Res | 2022 | 36550514 | PubTator, text mining | PubMed |
| Spatially resolved transcriptomics reveals genes associated with the vulnerability of middle temporal gyrus in Alzheimer's disease. | Acta Neuropathol Commun | 2022 | 36544231 | PubTator, text mining | PubMed |
| Epigenetics of type 2 diabetes and diabetes-related outcomes in the Strong Heart Study. | Clin Epigenetics | 2022 | 36529747 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28996/papers?page=13